Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $77.43 million. The enterprise value is $89.09 million.
| Market Cap | 77.43M |
| Enterprise Value | 89.09M |
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 140.07 million shares outstanding. The number of shares has increased by 12.25% in one year.
| Current Share Class | 140.07M |
| Shares Outstanding | 140.07M |
| Shares Change (YoY) | +12.25% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 12.55% |
| Owned by Institutions (%) | 14.31% |
| Float | 54.10M |
Valuation Ratios
The trailing PE ratio is 18.43.
| PE Ratio | 18.43 |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.79 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 7.62 |
| P/OCF Ratio | 6.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.12, with an EV/FCF ratio of 8.77.
| EV / Earnings | 17.92 |
| EV / Sales | 0.67 |
| EV / EBITDA | 7.12 |
| EV / EBIT | 12.23 |
| EV / FCF | 8.77 |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.56.
| Current Ratio | 2.65 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 2.83 |
| Interest Coverage | 1.98 |
Financial Efficiency
Return on equity (ROE) is 10.59% and return on invested capital (ROIC) is 7.66%.
| Return on Equity (ROE) | 10.59% |
| Return on Assets (ROA) | 4.84% |
| Return on Invested Capital (ROIC) | 7.66% |
| Return on Capital Employed (ROCE) | 11.26% |
| Weighted Average Cost of Capital (WACC) | 4.91% |
| Revenue Per Employee | $577,272 |
| Profits Per Employee | $21,435 |
| Employee Count | 232 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, XTNT has paid $2.03 million in taxes.
| Income Tax | 2.03M |
| Effective Tax Rate | 28.97% |
Stock Price Statistics
The stock price has increased by +8.39% in the last 52 weeks. The beta is -0.16, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | +8.39% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 57.30 |
| Average Volume (20 Days) | 173,438 |
Short Selling Information
The latest short interest is 12,780, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 12,780 |
| Short Previous Month | 23,175 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, XTNT had revenue of $133.93 million and earned $4.97 million in profits. Earnings per share was $0.03.
| Revenue | 133.93M |
| Gross Profit | 84.27M |
| Operating Income | 7.28M |
| Pretax Income | 7.00M |
| Net Income | 4.97M |
| EBITDA | 12.51M |
| EBIT | 7.28M |
| Earnings Per Share (EPS) | $0.03 |
Balance Sheet
The company has $17.05 million in cash and $28.72 million in debt, giving a net cash position of -$11.66 million or -$0.08 per share.
| Cash & Cash Equivalents | 17.05M |
| Total Debt | 28.72M |
| Net Cash | -11.66M |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | 50.95M |
| Book Value Per Share | 0.36 |
| Working Capital | 48.76M |
Cash Flow
In the last 12 months, operating cash flow was $12.55 million and capital expenditures -$2.38 million, giving a free cash flow of $10.16 million.
| Operating Cash Flow | 12.55M |
| Capital Expenditures | -2.38M |
| Depreciation & Amortization | 5.22M |
| Net Borrowing | -9.33M |
| Free Cash Flow | 10.16M |
| FCF Per Share | $0.07 |
Margins
Gross margin is 62.92%, with operating and profit margins of 5.44% and 3.71%.
| Gross Margin | 62.92% |
| Operating Margin | 5.44% |
| Pretax Margin | 5.23% |
| Profit Margin | 3.71% |
| EBITDA Margin | 9.34% |
| EBIT Margin | 5.44% |
| FCF Margin | 7.59% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.25% |
| Shareholder Yield | -12.25% |
| Earnings Yield | 6.42% |
| FCF Yield | 13.13% |
Analyst Forecast
The average price target for XTNT is $1.00, which is 80.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.00 |
| Price Target Difference | 80.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -0.3 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.3 |
| Piotroski F-Score | 8 |